Literature DB >> 34097050

Underlying Medical Conditions Associated With Severe COVID-19 Illness Among Children.

Lyudmyla Kompaniyets1, Nickolas T Agathis1,2, Jennifer M Nelson1,3, Leigh Ellyn Preston1, Jean Y Ko1,3, Brook Belay1, Audrey F Pennington1, Melissa L Danielson1, Carla L DeSisto1,2, Jennifer R Chevinsky1,2, Lyna Z Schieber1, Hussain Yusuf1, James Baggs1, William R Mac Kenzie1,3, Karen K Wong1,3, Tegan K Boehmer1,3, Adi V Gundlapalli1, Alyson B Goodman1,3.   

Abstract

Importance: Information on underlying conditions and severe COVID-19 illness among children is limited. Objective: To examine the risk of severe COVID-19 illness among children associated with underlying medical conditions and medical complexity. Design, Setting, and Participants: This cross-sectional study included patients aged 18 years and younger with International Statistical Classification of Diseases, Tenth Revision, Clinical Modification code U07.1 (COVID-19) or B97.29 (other coronavirus) during an emergency department or inpatient encounter from March 2020 through January 2021. Data were collected from the Premier Healthcare Database Special COVID-19 Release, which included data from more than 800 US hospitals. Multivariable generalized linear models, controlling for patient and hospital characteristics, were used to estimate adjusted risk of severe COVID-19 illness associated with underlying medical conditions and medical complexity. Exposures: Underlying medical conditions and medical complexity (ie, presence of complex or noncomplex chronic disease). Main Outcomes and Measures: Hospitalization and severe illness when hospitalized (ie, combined outcome of intensive care unit admission, invasive mechanical ventilation, or death).
Results: Among 43 465 patients with COVID-19 aged 18 years or younger, the median (interquartile range) age was 12 (4-16) years, 22 943 (52.8%) were female patients, and 12 491 (28.7%) had underlying medical conditions. The most common diagnosed conditions were asthma (4416 [10.2%]), neurodevelopmental disorders (1690 [3.9%]), anxiety and fear-related disorders (1374 [3.2%]), depressive disorders (1209 [2.8%]), and obesity (1071 [2.5%]). The strongest risk factors for hospitalization were type 1 diabetes (adjusted risk ratio [aRR], 4.60; 95% CI, 3.91-5.42) and obesity (aRR, 3.07; 95% CI, 2.66-3.54), and the strongest risk factors for severe COVID-19 illness were type 1 diabetes (aRR, 2.38; 95% CI, 2.06-2.76) and cardiac and circulatory congenital anomalies (aRR, 1.72; 95% CI, 1.48-1.99). Prematurity was a risk factor for severe COVID-19 illness among children younger than 2 years (aRR, 1.83; 95% CI, 1.47-2.29). Chronic and complex chronic disease were risk factors for hospitalization, with aRRs of 2.91 (95% CI, 2.63-3.23) and 7.86 (95% CI, 6.91-8.95), respectively, as well as for severe COVID-19 illness, with aRRs of 1.95 (95% CI, 1.69-2.26) and 2.86 (95% CI, 2.47-3.32), respectively. Conclusions and Relevance: This cross-sectional study found a higher risk of severe COVID-19 illness among children with medical complexity and certain underlying conditions, such as type 1 diabetes, cardiac and circulatory congenital anomalies, and obesity. Health care practitioners could consider the potential need for close observation and cautious clinical management of children with these conditions and COVID-19.

Entities:  

Year:  2021        PMID: 34097050     DOI: 10.1001/jamanetworkopen.2021.11182

Source DB:  PubMed          Journal:  JAMA Netw Open        ISSN: 2574-3805


  74 in total

1.  3a edizione Giornate della ricerca scientifica e delle esperienze professionali dei giovani: Società Italiana di Igiene, Medicina Preventiva e Sanità Pubblica (SItI) 25-26 marzo 2022.

Authors: 
Journal:  J Prev Med Hyg       Date:  2022-07-06

2.  Association of Household Deprivation, Comorbidities, and COVID-19 Hospitalization in Children in Germany, January 2020 to July 2021.

Authors:  Nico Dragano; Olga Dortmann; Jörg Timm; Matthias Mohrmann; Rosemarie Wehner; Christoph J Rupprecht; Maria Scheider; Ertan Mayatepek; Morten Wahrendorf
Journal:  JAMA Netw Open       Date:  2022-10-03

3.  Risk factors for disease severity and mortality of children with Covid-19: A study at a Vietnamese Children's hospital.

Authors:  Phung Nguyen The Nguyen; Tran Thanh Thuc; Nguyen Thanh Hung; Le Quoc Thinh; Ngo Ngoc Quang Minh; Dang Quoc Duy; Tran Minh Nhut; Nguyen Bich Y Linh; Tran Minh Tuan; Ngo Hoang Lam Giang; Vo Thi Minh Tuyen
Journal:  J Infect Chemother       Date:  2022-06-20       Impact factor: 2.065

4.  Effects of Sodium Thiosulfate During Resuscitation From Trauma-and-Hemorrhage in Cystathionine-γ-Lyase Knockout Mice With Diabetes Type 1.

Authors:  Michael Gröger; Melanie Hogg; Essam Abdelsalam; Sandra Kress; Andrea Hoffmann; Bettina Stahl; Enrico Calzia; Ulrich Wachter; Josef A Vogt; Rui Wang; Tamara Merz; Peter Radermacher; Oscar McCook
Journal:  Front Med (Lausanne)       Date:  2022-04-29

5.  Clinical Factors Associated with COVID-19 Severity in Chronic Hospitalized Infants and Toddlers: Data from a Center in the West Part of Romania.

Authors:  Alina Domnicu; Mirela Mogoi; Aniko Manea; Eugen Radu Boia; Marioara Boia
Journal:  Healthcare (Basel)       Date:  2022-04-27

Review 6.  Thrombotic events in critically ill children with coronavirus disease 2019 or multisystem inflammatory syndrome in children.

Authors:  Aleksandra S Dain; Leslie Raffini; Hilary Whitworth
Journal:  Curr Opin Pediatr       Date:  2022-06-01       Impact factor: 2.893

7.  Increased Severe Cases and New-Onset Type 1 Diabetes Among Children Presenting With Diabetic Ketoacidosis During First Year of COVID-19 Pandemic in Turkey.

Authors:  Eylem Kiral; Birgul Kirel; Merve Havan; Mehmet Keskin; Murat Karaoglan; Ahmet Yildirim; Murat Kangin; Mehmet Nur Talay; Tuba Urun; Umit Altug; Selman Kesici; Erennur Tufan; Ebru Kacmaz; Gurkan Bozan; Ebru Azapagasi; Mutlu Uysal Yazici; Zeynelabidin Ozturk; Osman Yesilbas; Gulay Karaguzel; Gulay Kaya; Ulkem Barlas; Muhterem Duyu; Merve Boyraz; Esra Sevketoglu; Nihal Akcay; Suna Hancili; Ayla Guven; Oǧuz Dursun; Nazan Ulgen Tekerek; Gokçen Ozcifci; Pinar Yazici; Eda Turanli; Tanil Kendirli; Fevzi Kahveci; Ayse Filiz Yetimakman; Agop Citak; Guntulu Şik; Ibrahim Bingol; Fatih Aygun; Cansu Durak; Resul Yilmaz; Fuat Bugrul; Yusuf Sari; Hakan Tekguç; Hatice Albayrak; Nazik Yener; Hasan Agin; Ekin Soydan; Dincer Yildizdas; Semine Ozdemir Dilek; Nilufer Yalindag; Feyza Incekoy-Girgin; Nuri Alacakir; Filiz Tutunculer; Mehmet Ozgur Arslanaoglu; Can Aydin; Muzaffer Bilgin; Enver Simsek; Ener Cagri Dinleyici
Journal:  Front Pediatr       Date:  2022-06-29       Impact factor: 3.569

8.  African Americans and the COVID-19 pandemic: A qualitative inquiry of preparedness, challenges, and strategies on how we can move forward.

Authors:  Jennifer Cunningham-Erves; Imari Parham; Leah Alexander; Jamal Moss; Iman Barre; Taneisha Gillyard; Jamaine Davis
Journal:  Soc Sci Med       Date:  2022-06-30       Impact factor: 5.379

Review 9.  Critically Ill Pediatric Patient and SARS-CoV-2 Infection.

Authors:  Jozef Klučka; Eva Klabusayová; Milan Kratochvíl; Tereza Musilová; Václav Vafek; Tamara Skříšovská; Martina Kosinová; Pavla Havránková; Petr Štourač
Journal:  Children (Basel)       Date:  2022-04-11

10.  Important Considerations for COVID-19 Vaccination of Children With Developmental Disabilities.

Authors:  Sarah C Tinker; Mary E Cogswell; Georgina Peacock; A Blythe Ryerson
Journal:  Pediatrics       Date:  2021-07-16       Impact factor: 9.703

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.